Ottobock invests in NeuroTech company ONWARD® Medical
mehr
Storys zum Thema Medizinische Behandlung
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
mehrBosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
mehrcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 DokumentemehrcanSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
mehr- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
mehr Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrExtension of Wastewater Treatment Plant at Koehler Paper in Kehl
mehrLeipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
Ein DokumentmehrTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
mehrWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
mehr- 2
OPTIMA cancer project announces the Region Uppsala as new partner
mehr New Source of Stem Cells in Injury-Affected Brains of Patients
mehr- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
Ein Dokumentmehr OD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developments
mehr- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr A New Ally in Fighting Brain Diseases: Our Very Own Skull
mehr- 4
PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets
mehr - 2
CARAMBA: New Hope for Multiple Myeloma Patients
mehr RHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June
mehrAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
mehr- 5
Press Release - hubergroup India expands its support for rural healthcare
Ein Dokumentmehr The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehr
123Nächste